LONDON--In an interview with Reuters here earlier this month, Alex Titomirov, president and CEO of the information technology company InforMax, said the firm will soon open sales offices in London and Germany to expand its presence in the European drug-development software market. The US-based company, which opened a Paris office last year, will nearly double its staff to around 70 this year in an effort to compete with such entrenched European players as Oxford Molecular Group and MDL Information Systems, Titomirov revealed.